Australia's Osteopore climbs most in 8 months on deal to expand U.S. sales

Osteopore

11/04/2023 04:41

** Shares of medical technology firm Osteopore  OSX.AX  rise
as much as 20.7% to A$0.105, highest intraday gain since Aug.
10, 2022
    ** Co's U.S. sales distributor Bioplate Inc enters into
sub-distribution partnership with custom prosthetics maker
Kelyniam 
    ** Kelyniam to focus on securing sales in about 20 hospitals
in 8 U.S. states
    ** Shares hit highest since March 13
    ** As of last close, OSX down 41.4% YTD 

 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))